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Pre-dialysis albumin was 32.8þ/4.1g/L in Australian indigenous patients and
36.2þ/-4.5g/L in non-indigenous patients (p¼ 0.003). The difference between
pre-dialysis and post-dialysis albumin was -4.0þ/-2.8g/L in indigenous
patients and -1.0þ/-1.9g/L in non-indigenous patients (p¼0.000). Intra-dialytic
weight gain was 3.0þ/-2.6kg in indigenous patients and 2.0þ/-0.8kg in non-
indigenous patients (p¼0.010). Serum sodium and bicarbonate were 136.2þ/-
2.7mmol/L and 22.3þ/-1.7mmol/L in indigenous patients and 138.5þ/-
2.3mmol/L and 25.2þ/-5.8mmol/L in non-indigenous patients
(p¼0.010,0.003). Glucose, HbA1c and triglyceride were 9.7þ/-4.6mmol/L,
7.0þ/-1.7% and 2.2þ/-1.3mmol/L in indigenous patients and 7.0þ/-2.8mmol/
L, 6.2þ/-1.0% and 1.4þ/-0.7mmol/L in non-indigenous patients (p¼ 0.005,
0.047, 0.016). No differences were observed in dry weight, PG-SGA, post-
dialysis albumin, serum potassium, urea, creatinine, parathyroid hormone,
phosphate, calcium, C-reactive protein or hemoglobin.
This study indicates that differences exist between Australian indigenous and
non-indigenous maintenance hemodialysis patients, with indigenous patients
less likely to be meeting recommendations.
http://dx.doi.org/10.1016/j.krcp.2012.04.580257
GUANIDINOACETIC ACID(GAA) IN PATIENTS WITH CHRONIC KIDNEY
DISEASE(CKD) AND DIABETES MELLITUS(DM)
Yoshiharu Tsubakihara, Terumasa Hayashi, Tatsuya Shoji
Osaka General Medical Center, Osaka, Japan
GAA is the precursor of creatine, an essential in the energy metabolism
of muscle and nerve tissue. GAA is mainly produced in the kidney. GAA
production was reported to be suppressed in the streptozotocin-induced
DM rats. However, GAA metabolism has not been really investigated in
CKD or DM patients. In this study, we determined serum level(S) and
urinary excretion(U) of GAA and creatinine(Cr) in patients with chronic
glomerulonephritis (CGN) and DM. The subjects were 15 healthy adults, 92
patients with CGN and 27 patients with non insulin-dependent DM
nephropathy. S and U-GAA were determined with HPLC. As shown in the
Table describing mean values, U-GAA of early stage CKD patients was
signiﬁcantly lower than healthy subject. And S-GAA decreased with loss of
renal function or with U-Cr, especially in DM patients.N S-Cr U-Cr S-GAA U-GAA(mg/dL) (mg/day) (mg/dL) (mg/day)Normal 15 0.9 1633 38.2 103.0
CGN(Ccr490mL/min) 12 1 1742 41.1 41.3nCGN(Ccro90mL/min) 24 1.5n 1385n 37.7 39.2n
CGN(Ccro30mL/min) 56 7.1n 715n 24.4n 5.9n
DM(Ccr460mL/min) 16 0.9 775n 27.8n 46.2nDM(Ccro60mL/min) 11 5.0n 581n 22.1n 2.3nIn conclusion, GAA production in the kidney decreased in CKD patients,
suggesting GAA deﬁciency was a reason of muscle wasting of CKD and DM
patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.581258
EFFECTS OF GUANIDINOACETIC ACID(GAA) SUPPLEMENTATION IN RATS
WITH CHRONIC RENAL FAILURE(CRF)
Yoshiharu Tsubakihara, Terumasa Hayashi, Tatsuya Shoji
Osaka General Medical Center, Osaka, Japan
GAA is the precursor of creatine(CRT), an essential in the energy
metabolism of muscle and nerve tissue. GAA is mainly produced in the
kidney. We reported the GAA deﬁciency in CRF patients. This study was
designed to assess the effects of GAA supplementation(10 mg,100 mg/day
orally for 4 weeks respectively) for the muscle capabilities in CRF rats
prepared by 5/6 nephrectomy. Muscle power was assessed by the sliding
angle of the inclined screen test, and physical strength was evaluated by
the time to survive in water (forced swimming method). GAA and CRT
concentrations in serum, muscle and other organs were signiﬁcantlydecreased in CRF rats. GAA administrations signiﬁcantly increased CRT
content in muscle, and improved muscle capabilities dose-dependently.muscle power physical strengthsliding angle; 1 swimming time; min
Sham 55.270.9 52.073.8
CRF(GAA 0) 42.371.9* 21.971.2*
CRF(GAA 10 mg) 47.471.3*$ 25.571.1*$
CRF(GAA 100 mg) 48.872.1*$ 29.073.3*$*; po0.05 vs Sham $; po0.05 vs GAA 0
In conclusion, we demonstrated a deﬁciency of GAA and CRT, and muscle
weekness in CRF rats. However, oral GAA supplementation could recover
muscle content of CRT and muscle capabilities in these rats.
http://dx.doi.org/10.1016/j.krcp.2012.04.582259
IMPACT OF IDPN ON KT/V
Dukkipati R, Moore E., VanBolt G, Kalantar-Zadeh K
UCLA Torrence California Pentec Health Inc. Boothwyn, PA, USA.
The administration of intradialytic parenteral nutrition (IDPN) and the
impact it has on Kt/V has not been thoroughly examined. The available
literature addressing the inﬂuence of IDPN on Kt/V is limited and the
observations are conﬂicting. Some studies have observed little or no signiﬁcant
change with IDPN administration. In contrast, one randomized, crossover study
by McCann et al. of patients receiving IDPN observed a signiﬁcant decrease.
When amino acid (AA), dextrose and lipid components were administered a
signiﬁcant reduction in mean Kt/V resulted. When solutions containing only AA
were administered, Kt/V was signiﬁcantly less then when IDPN was withheld
Administration of IDPN without AA resulted in a mean Kt/V not signiﬁcantly
different from the mean Kt/V when IDPN was withheld. AA containing IDPN
reduced mean Kt/V by 18–23%. By personal communication with McCann, it
was thought the amount of carbohydrate (CHO) determined whether the Kt/V
was impacted when they studied further (unpublished). The authors found that
by increasing the CHO, the Kt/V was not impacted (lower) and theorized that
inadequate CHO resulted in catabolized protein generating urea. To investigate
this further, a retrospective analysis was performed of the Pentec Health IDPN
internal data base consisting of 489 patients that met inclusion and exclusion
criteria. For this group: the age was 66.23þ13.38 years; BMI was 25.79þ56;
239 males (49%) and 250 females (51%); 304 patients with DM (62%); 430
patients with HTN (88%). Baseline albumin was 2.98þ38 g/dL and baseline
creatinine was 6.03þ2.10mg/dL. Results are below TableKt/V (mean þ SD)Baseline Month 1 Month 2 Month 3
1.65þ .34 1.44þ .36 1.43þ .35 1.44þ .34A repeated measures ANOVA indicated a statistically signiﬁcant
difference (po0.0001). A Tukey’s adjustment resulted in non-signiﬁcant
differences between month 1 and month 2 (p¼0.995), month 1 and month
3 (p¼0.987), and month 2 and month 3 (p¼0.936). In conclusion, the
initial decrease in Kt/V was followed by a period of stabilization, and the
mean Kt/V never dropped below the KDOQI recommendation of 1.2.
http://dx.doi.org/10.1016/j.krcp.2012.04.583260
A FULL COLOR VISUAL EDUCATING TOOL TO IMPROVE RENAL
DIET COMPLIANCE
Cecile Verseput
Johannesburg, Gauteng, South Africa.
The objective is to simplify Renal diet education of a newly diagnosed,
illiterate/non-English speaking CKD patient by using a 5 step concept that is
explained by a fully illustrated color manual. The 5 steps to be followed are as
follows:
Step 1. What foods are eaten daily? The renal dietitian is faced with many
challenges when taking a diet history & educating a newly diagnosed CKD
patient. It is of utmost importance to tailor education to speciﬁc patient’s
